The Lattice (Official 3DHEALS Podcast)

Interview with Roger Kuan,3DHEALS2020 Speaker on Intellectual Property

May 03, 2020 Roger Kuan
The Lattice (Official 3DHEALS Podcast)
Interview with Roger Kuan,3DHEALS2020 Speaker on Intellectual Property
Chapters
The Lattice (Official 3DHEALS Podcast)
Interview with Roger Kuan,3DHEALS2020 Speaker on Intellectual Property
May 03, 2020
Roger Kuan

Today I had the opportunity to interview upcoming 3DHEALS2020 speaker, Roger Kuan, an intellectual property attorney who specializes in 3D printed medical devices and bioprinting innovations. Roger shared his perspectives on how a startup should approach legal help, what COVID19 could impact IP law and startups in the healthcare and other pearls of wisdom.

Roger's more in-depth written interview can be also found here.

Roger Kuan is a partner with McDermott Will & Emery and he focuses his practice on intellectual property (IP) procurement/portfolio management, IP transactions and strategic IP counseling for life sciences clients (e.g., research tools, analytical instrumentation/software, medical devices, diagnostics, biomanufacturing systems, etc.) with a focus on emerging technologies such as digital health (e.g., mobile apps, clinical decision support software, digital therapeutics, AI/ML imaging diagnostics, etc.), personalized medicine (e.g., genomic sequencing platforms, AI/ML computational genomics/bioinformatics, molecular diagnostics, etc.) and 3D printing/bioprinting. He has extensive experience in intellectual property strategy and management, preparation and prosecution (utility/design patents, trademarks, and trade dress), counseling and litigation, licensing and technology transactions, freedom-to-operate clearances, monetization, IP due diligence, IP risk recognition and mitigation, and dispute resolution. He served as Director IP Counsel at a multinational biotechnology company, where he managed a team to support the worldwide IP needs of the company’s life sciences tools, bioproduction/biomanufacturing, molecular diagnostics, and nucleic acid sequencing system/software platforms. Prior to finishing his law degree, Roger worked in the life sciences industry for several Fortune 500 pharmaceutical, medical device, and chemical companies. He has held professional positions in the R&D, sales, engineering, and regulatory affairs organizations.

Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)

Show Notes

Today I had the opportunity to interview upcoming 3DHEALS2020 speaker, Roger Kuan, an intellectual property attorney who specializes in 3D printed medical devices and bioprinting innovations. Roger shared his perspectives on how a startup should approach legal help, what COVID19 could impact IP law and startups in the healthcare and other pearls of wisdom.

Roger's more in-depth written interview can be also found here.

Roger Kuan is a partner with McDermott Will & Emery and he focuses his practice on intellectual property (IP) procurement/portfolio management, IP transactions and strategic IP counseling for life sciences clients (e.g., research tools, analytical instrumentation/software, medical devices, diagnostics, biomanufacturing systems, etc.) with a focus on emerging technologies such as digital health (e.g., mobile apps, clinical decision support software, digital therapeutics, AI/ML imaging diagnostics, etc.), personalized medicine (e.g., genomic sequencing platforms, AI/ML computational genomics/bioinformatics, molecular diagnostics, etc.) and 3D printing/bioprinting. He has extensive experience in intellectual property strategy and management, preparation and prosecution (utility/design patents, trademarks, and trade dress), counseling and litigation, licensing and technology transactions, freedom-to-operate clearances, monetization, IP due diligence, IP risk recognition and mitigation, and dispute resolution. He served as Director IP Counsel at a multinational biotechnology company, where he managed a team to support the worldwide IP needs of the company’s life sciences tools, bioproduction/biomanufacturing, molecular diagnostics, and nucleic acid sequencing system/software platforms. Prior to finishing his law degree, Roger worked in the life sciences industry for several Fortune 500 pharmaceutical, medical device, and chemical companies. He has held professional positions in the R&D, sales, engineering, and regulatory affairs organizations.

Support the show (https://www.paypal.com/cgi-bin/webscr?cmd=_s-xclick&hosted_button_id=STF9STPYVE2GG&source=url)